An experiment at SLAC's X-ray laser has revealed in atomic detail how a hypertension drug binds to a cellular receptor that plays a key role in regulating blood pressure.

Developed at SLAC’s LCLS, it could also yield new information from hard-to-study samples in materials science, chemistry and other fields.

An X-ray laser experiment could lead to new drugs that lessen the side effects caused by powerful painkillers like morphine.

Research reveals that the bacterial immune system can better destroy viral attackers by saving genetic records of previously encountered viruses.

Scientists have assembled an exotic toolbox for experiments that tap into the brightest X-rays on the planet.

Research performed in part at SLAC has provided new insights into how "TH proteins" couple two important processes needed to maintain healthy cells.

A scientist at Germany’s DESY lab who participated in pioneering studies at SLAC's LCLS has been awarded a scientific prize by a research foundation.

Researchers captured the highest-resolution snapshots ever taken with an X-ray laser that show changes in a protein’s structure over time.

Scientists at the Department of Energy’s SLAC National Accelerator Laboratory are combining the speed and precision of robots with one of the brightest X-ray lasers on the planet for pioneering studies of proteins important to biology and drug discovery.

A new experimental station in development at SLAC will expand capabilities for atomic-scale explorations in human health, biology, energy and environmental science.

Discovery at SLAC's Synchrotron Could Lead to New Drug Designs, Treatments

SSRL protein crystallography expert joined research effort that could lead to a safe and effective alternative to chemotherapy.